Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA [0.03%]
用于美国慢性免疫性血小板减少症患者的 fostamatinib 的应用评价
Kate McKeage,Katherine A Lyseng-Williamson
Kate McKeage
Oral fostamatinib is an orally administered small molecule spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adults with chronic immune thrombocytopenia (ITP) who have an inadequate response to a previous treatment. Fosta...
Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use [0.03%]
肺纤维化用药：吡非尼酮片上市后的临床应用评估
Katherine A Lyseng-Williamson
Katherine A Lyseng-Williamson
Pirfenidone (Esbriet®) is available as capsules containing 267 mg of pirfenidone and, more recently, as bioequivalent tablets containing 267, 534 or 801 mg of pirfenidone. Both formulations are indicated to treat idiopathic pulmonary fibro...
Emma D Deeks,Gillian M Keating
Emma D Deeks
Afatinib [Giotrif® (EU); Gilotrif® (USA)] is an orally administered, irreversible inhibitor of the ErbB family of tyrosine kinases that provides an important first-line treatment option for advanced non-small cell lung cancer (NSCLC) with...
Stability of medicines after repackaging into multicompartment compliance aids: eight criteria for detection of visual alteration [0.03%]
改良型多隔间顺应性辅助包装中药品再包装后的稳定性：八项可视化变化判别标准
Valerie Albert,Michael Lanz,Georgios Imanidis et al.
Valerie Albert et al.
Introduction: Multicompartment compliance aids (MCA) are widely used by patients. They support the management of medication and reduce unintentional nonadherence. MCA are filled with medicines unpacked from their original...
Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series [0.03%]
从苯扎贝特切换至依折麦布治疗的他汀类药物治疗患者的病例系列研究回顾性分析
Richard S Castaldo
Richard S Castaldo
Introduction: Patients receiving statin therapy for dyslipidaemia often require treatment with an additional agent to control triglyceride levels. Options for add-on therapy include fibrates and omega-3 fatty acids. This ...
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands [0.03%]
爱尔兰和荷兰针对呼吸道合胞病毒预防的家庭护理项目的回顾
Barbara Whelan,Elles Musters,Amanda Murray et al.
Barbara Whelan et al.
Severe infection of infants with respiratory syncytial virus (RSV) is a leading cause of morbidity in the developed world and mortality in the developing world. Prophylaxis using palivizumab in infants at risk for severe RSV disease reduces...
Do physicians communicate the adverse effects of medications that older patients want to hear? [0.03%]
医师是否向老年患者传达他们想了解的药物不良反应信息？
Derjung M Tarn,Ariela Wenger,Jeffrey S Good et al.
Derjung M Tarn et al.
Background and objectives: Physicians routinely discuss adverse effects of medications, but whether discussions match older patients' desire for information is unexplored. This study compares patient preferences for adver...